UPDATE : Monday, September 16, 2019
상단여백
Invossa victims, Kolon shareholders demand apology, compensation by Jeong Sae-im 2019-08-27 15:40
HLB to test rivoceranib+Lonsurf in colon cancer by Jeong Sae-im 2019-08-27 15:39
Regulator decides to delist Kolon TissueGene by Jeong Sae-im 2019-08-27 12:15
Possibility proved to use AI in sleep staging classification by Choi Gwang-seok 2019-08-26 17:03
Temple stay beneficial to mental health, SNUH says by Choi Gwang-seok 2019-08-26 15:01
라인
'Myongji Hospital to change concept of sports medicine in Korea’ by Lee Han-soo 2019-08-26 11:43
Pharmaceutical sector’s job growth twice of all industries’ average by Jeong Sae-im 2019-08-26 11:39
Invossa still effective despite mislabeling, maker claims by Lee Han-soo 2019-08-23 20:16
Medipost’s Pneumostem gets FDA’s fast-track designation by Lee Han-soo 2019-08-23 17:51
Vivozon finishes P3 trial for nonnarcotic analgesics by Lee Han-soo 2019-08-23 16:03
라인
49 international healthcare experts receive Korean medical training by Choi Gwang-seok 2019-08-23 16:02
'Surgery more viable option for gastroesophageal reflux disease' by Lee Han-soo 2019-08-23 15:02
HLB wins FDA nod for P2 trial on rivoceranib in adenoid cystic carcinoma by Jeong Sae-im 2019-08-23 15:02
Ministry OKs P1 trial into Haim Bio’s metabolism anticancer drug by Lee Han-soo 2019-08-23 13:53
GenNBio to test transplanting pig’s pancreatic islet into human next year by Jeong Sae-im 2019-08-23 13:53
라인
'Peptron's Parkinson's disease treatment blocks levodopa side effects' by Lee Han-soo 2019-08-22 17:53
Japan gives further nod to Celltrion's breast cancer biosimilar by Lee Han-soo 2019-08-22 16:47
‘Drug firm’s pick of doctor to attend conference overseas illegal’ by Kim Yun-mi 2019-08-22 15:45
SK Biopharmaceutical’s sleepiness drug initially aimed to treat depression by Lee Hye-seon 2019-08-22 15:37
Tego Science’s diabetic foot ulcer treatment gets insurance benefit by Lee Han-soo 2019-08-22 15:34
여백
여백
여백
Back to Top